|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 895,000.00 KRW | +4.68% |
|
+5.05% | +174.12% |
| 12-04 | Innospace Secures KRW474.2 Million Development Contract for Reusable Tech Demonstrator Umbilical System | MT |
| 11-28 | Asian Stocks Post Mixed Results on Fed Policy Shifts, Tech Rally | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.67 | 2.33 | 1.8 | 2.49 | 3.18 | |||||
Return on Total Capital | 2.9 | 3.92 | 3.34 | 5.26 | 6.46 | |||||
Return On Equity % | 5.64 | 8.72 | 2.92 | 22.69 | 31.28 | |||||
Return on Common Equity | 4.78 | 9.21 | 5.68 | 25.6 | 53.27 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.08 | 20.17 | 20.23 | 22.81 | 25.51 | |||||
SG&A Margin | 10.55 | 10.17 | 10.8 | 11 | 8.53 | |||||
EBITDA Margin % | 9.19 | 9.65 | 9.71 | 11 | 17.17 | |||||
EBITA Margin % | 5.98 | 7.12 | 7.02 | 8.22 | 14.87 | |||||
EBIT Margin % | 4.57 | 5.95 | 5.78 | 7.38 | 14.23 | |||||
Income From Continuing Operations Margin % | 3.1 | 4.7 | 1.75 | 10.44 | 22.34 | |||||
Net Income Margin % | 2.28 | 3.94 | 3.07 | 8.74 | 20.45 | |||||
Net Avail. For Common Margin % | 2.28 | 3.94 | 2.5 | 8.74 | 20.2 | |||||
Normalized Net Income Margin | 1.34 | 2.84 | 3.33 | 6.22 | 13.17 | |||||
Levered Free Cash Flow Margin | 2.06 | 9.22 | 27.51 | 12.19 | -17.38 | |||||
Unlevered Free Cash Flow Margin | 2.84 | 9.85 | 28.27 | 13.32 | -16.03 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.59 | 0.63 | 0.5 | 0.54 | 0.36 | |||||
Fixed Assets Turnover | 2.7 | 3.14 | 2.52 | 2.74 | 1.82 | |||||
Receivables Turnover (Average Receivables) | 4.7 | 6.31 | 5.52 | 5.35 | 2.13 | |||||
Inventory Turnover (Average Inventory) | 2.91 | 3.21 | 2.88 | 2.87 | 1.83 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.31 | 1.43 | 0.99 | 0.76 | 0.89 | |||||
Quick Ratio | 0.62 | 0.85 | 0.56 | 0.33 | 0.48 | |||||
Operating Cash Flow to Current Liabilities | 0.11 | 0.23 | 0.18 | 0.12 | 0.05 | |||||
Days Sales Outstanding (Average Receivables) | 77.83 | 57.8 | 66.12 | 68.28 | 171.65 | |||||
Days Outstanding Inventory (Average Inventory) | 125.66 | 113.87 | 126.61 | 127.11 | 200.19 | |||||
Average Days Payable Outstanding | 30.34 | 27.93 | 31.67 | 34.11 | 40.77 | |||||
Cash Conversion Cycle (Average Days) | 173.15 | 143.73 | 161.07 | 161.29 | 331.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 82.89 | 70.73 | 88.58 | 89.19 | 94.05 | |||||
Total Debt / Total Capital | 45.32 | 41.43 | 46.97 | 47.14 | 48.47 | |||||
LT Debt/Equity | 58.59 | 49.98 | 47.03 | 33.54 | 39.53 | |||||
Long-Term Debt / Total Capital | 32.03 | 29.27 | 24.94 | 17.73 | 20.37 | |||||
Total Liabilities / Total Assets | 68.41 | 64.41 | 74.1 | 76.01 | 73.76 | |||||
EBIT / Interest Expense | 3.67 | 5.96 | 4.7 | 4.07 | 6.59 | |||||
EBITDA / Interest Expense | 7.38 | 9.67 | 7.9 | 6.07 | 7.96 | |||||
(EBITDA - Capex) / Interest Expense | 4.52 | 7.08 | 5.45 | 3.4 | 5.57 | |||||
Total Debt / EBITDA | 5.07 | 4.49 | 5.48 | 4.06 | 5.54 | |||||
Net Debt / EBITDA | 2.21 | 0.25 | 0.5 | 2.21 | 3.81 | |||||
Total Debt / (EBITDA - Capex) | 8.27 | 6.14 | 7.94 | 7.25 | 7.91 | |||||
Net Debt / (EBITDA - Capex) | 3.61 | 0.34 | 0.72 | 3.95 | 5.45 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.09 | 20.55 | 18.01 | 32.56 | 42.47 | |||||
Gross Profit, 1 Yr. Growth % | 4.9 | 21.06 | 30.09 | 41.41 | 101.04 | |||||
EBITDA, 1 Yr. Growth % | 27.34 | 26.64 | 23.7 | 55.22 | 106.84 | |||||
EBITA, 1 Yr. Growth % | 33.26 | 43.67 | 30.81 | 59.28 | 148.56 | |||||
EBIT, 1 Yr. Growth % | 47.28 | 56.9 | 36.91 | 72.36 | 169.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 1.42 | 83.17 | -45.41 | 709.62 | 179.42 | |||||
Net Income, 1 Yr. Growth % | -8.15 | 108.01 | -20.49 | 318.48 | 181.21 | |||||
Normalized Net Income, 1 Yr. Growth % | 1.5 | 155.79 | 98.06 | 152.05 | 179.67 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -6.56 | 108.75 | 1.59 | 381.42 | 185.2 | |||||
Accounts Receivable, 1 Yr. Growth % | -17.61 | -1.27 | 34.73 | 38.57 | 318.35 | |||||
Inventory, 1 Yr. Growth % | 19.62 | 0.89 | 25.51 | 32.62 | 119.28 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.59 | 0.76 | 53.63 | 14.46 | 140.04 | |||||
Total Assets, 1 Yr. Growth % | 8.69 | 16.7 | 37.22 | 28.98 | 121.75 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.38 | 24.87 | -4.33 | 48 | -122.26 | |||||
Common Equity, 1 Yr. Growth % | 4.49 | 11.22 | -0.91 | 23.48 | 41.57 | |||||
Cash From Operations, 1 Yr. Growth % | -39.21 | 127.72 | 53.97 | -8.8 | 0.2 | |||||
Capital Expenditures, 1 Yr. Growth % | 23.11 | -12.3 | 18.44 | 130.44 | 27.54 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -55.03 | 440.45 | 241.59 | -16.24 | -278.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -46.21 | 318.61 | 226.93 | -11.89 | -251.6 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.32 | 10.39 | 10.86 | 29.96 | 26.17 | |||||
Gross Profit, 2 Yr. CAGR % | 15.91 | 12.69 | 11.28 | 44.88 | 37.82 | |||||
EBITDA, 2 Yr. CAGR % | 53.32 | 26.99 | 13.95 | 41.65 | 70.55 | |||||
EBITA, 2 Yr. CAGR % | 69.07 | 38.36 | 20.15 | 48.01 | 86.03 | |||||
EBIT, 2 Yr. CAGR % | 113.9 | 52.02 | 24.58 | 58.25 | 99.75 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 82.89 | 36.3 | -16.62 | 115.79 | 356.2 | |||||
Net Income, 2 Yr. CAGR % | 93.81 | 38.22 | 28.6 | 79.91 | 243.05 | |||||
Normalized Net Income, 2 Yr. CAGR % | 313.41 | 61.13 | 74.83 | 129.98 | 153.25 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 96.43 | 39.66 | 16.12 | 125.29 | 252.38 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.6 | -9.81 | 15.33 | 41.96 | 140.77 | |||||
Inventory, 2 Yr. CAGR % | 9.78 | 9.86 | 12.53 | 33.7 | 70.53 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.89 | 3.63 | 24.42 | 33.36 | 65.75 | |||||
Total Assets, 2 Yr. CAGR % | 13.12 | 12.62 | 26.55 | 33.01 | 69.12 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.49 | 21.07 | 9.3 | 18.22 | -42.61 | |||||
Common Equity, 2 Yr. CAGR % | 4.7 | 7.8 | 4.98 | 10.51 | 32.22 | |||||
Cash From Operations, 2 Yr. CAGR % | 177.78 | 17.66 | 87.25 | 18.5 | -4.41 | |||||
Capital Expenditures, 2 Yr. CAGR % | 4.79 | 3.91 | 1.92 | 65.21 | 71.43 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -46.57 | 55.9 | 305.31 | 47.17 | 19.79 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -34.75 | 50.05 | 250.01 | 48.46 | 12.87 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.08 | 12.94 | 7.5 | 20.71 | 26.59 | |||||
Gross Profit, 3 Yr. CAGR % | 11.75 | 17.6 | 9.11 | 25.95 | 41.27 | |||||
EBITDA, 3 Yr. CAGR % | 32.83 | 43.85 | 18.25 | 28.18 | 55.5 | |||||
EBITA, 3 Yr. CAGR % | 36.34 | 60.14 | 24.37 | 34.22 | 68.22 | |||||
EBIT, 3 Yr. CAGR % | 43.16 | 92.91 | 31.73 | 41.6 | 79.64 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 51.11 | 82.99 | -10.99 | 81 | 128.75 | |||||
Net Income, 3 Yr. CAGR % | 36.02 | 98.43 | 14.95 | 88.83 | 108.79 | |||||
Normalized Net Income, 3 Yr. CAGR % | 83.81 | 252.27 | 45.84 | 101.34 | 137.86 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 37.72 | 100.45 | 8.01 | 88.87 | 135.68 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.19 | -4.86 | 3.1 | 25.77 | 103.52 | |||||
Inventory, 3 Yr. CAGR % | 24.95 | 6.73 | 14.85 | 21.72 | 57.67 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.52 | 6.11 | 18.17 | 21.46 | 62.22 | |||||
Total Assets, 3 Yr. CAGR % | 18.09 | 14.3 | 20.29 | 27.34 | 57.72 | |||||
Tangible Book Value, 3 Yr. CAGR % | -7.02 | 7.33 | 11.93 | 20.39 | -32.24 | |||||
Common Equity, 3 Yr. CAGR % | 6.03 | 6.83 | 4.82 | 10.75 | 20.02 | |||||
Cash From Operations, 3 Yr. CAGR % | 254.71 | 159.98 | 28.7 | 47.33 | 12.06 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.17 | -1.25 | 8.54 | 33.77 | 51.55 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -13.29 | 15.55 | 94.76 | 118.39 | 54.82 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.09 | 21.24 | 87.48 | 102.14 | 47.16 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.28 | 12.76 | 9.18 | 16.01 | 16.38 | |||||
Gross Profit, 5 Yr. CAGR % | 15.75 | 12.64 | 11.56 | 21.84 | 23 | |||||
EBITDA, 5 Yr. CAGR % | 92.08 | 21.18 | 24.93 | 37.7 | 38.12 | |||||
EBITA, 5 Yr. CAGR % | 68.58 | 19.49 | 29.62 | 47.2 | 47.58 | |||||
EBIT, 5 Yr. CAGR % | 32.51 | 20.43 | 35.42 | 67 | 57.46 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 92.42 | -2.69 | 19.12 | 81.76 | 72.92 | |||||
Net Income, 5 Yr. CAGR % | 84.13 | -6.06 | 33.01 | 90.8 | 77.03 | |||||
Normalized Net Income, 5 Yr. CAGR % | 40.44 | 7.84 | 80.16 | 168.48 | 83.98 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 85.78 | -5.15 | 28.64 | 91.86 | 74.63 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.27 | 2.46 | 5.11 | 11.66 | 46.97 | |||||
Inventory, 5 Yr. CAGR % | 22.84 | 15.86 | 19.82 | 16.8 | 36.45 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.19 | 8.53 | 17.13 | 16.27 | 35.6 | |||||
Total Assets, 5 Yr. CAGR % | 18.17 | 14.34 | 21.4 | 21.45 | 37.84 | |||||
Tangible Book Value, 5 Yr. CAGR % | -11.28 | -1.9 | -0.81 | 11.56 | -14.54 | |||||
Common Equity, 5 Yr. CAGR % | 2.98 | 4.32 | 5.61 | 8.29 | 14.98 | |||||
Cash From Operations, 5 Yr. CAGR % | 63.22 | 38.25 | 174.72 | 89.87 | 14.26 | |||||
Capital Expenditures, 5 Yr. CAGR % | 35.23 | 13.26 | 6.8 | 21.32 | 30.32 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 0.31 | 44.02 | 60.67 | 24.35 | 51.67 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.14 | 50.36 | 66.13 | 28.59 | 45.06 |
- Stock Market
- Equities
- A012450 Stock
- Financials Hanwha Aerospace Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















